Precigen (PGEN) Non Operating Income (2012 - 2026)
Precigen's (PGEN) quarterly Non Operating Income came in at -$1.9 million in Q1 2026, up 93.87% year-on-year from -$998100.6 in Q1 2025, and down 5.33% on a QoQ basis from -$1.8 million in Q4 2025.
Precigen (PGEN) Non Operating Income (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Non Operating Income data on file, last reported at -$1.9 million in Q1 2026.
- On a quarterly basis, Non Operating Income rose 93.87% year-over-year to -$1.9 million in Q1 2026; TTM through Mar 2026 was -$110.5 million, a 338.55% decrease from a year earlier, with the FY2025 full-year figure at -$140.1 million, down 2101.6% from the prior year.
- Non Operating Income for Q1 2026 stood at -$1.9 million, down from -$1.8 million in the prior quarter.
- Over the last five years, Non Operating Income for PGEN reached as high as $8.7 million in Q4 2024 and fell as low as -$111.9 million in Q3 2025.
- Historically, Non Operating Income has averaged -$8.0 million across 5 years, with a median of -$372000.0 in 2022.
- On a YoY basis, Non Operating Income climbed as much as 1323.61% in 2025 and fell as far as 5007.78% in 2025.
- Year by year, Non Operating Income stood at -$372000.0 in 2022, then soared by 324.73% to $836000.0 in 2023, then soared by 940.91% to $8.7 million in 2024, then plunged by 121.11% to -$1.8 million in 2025, then slipped by 5.33% to -$1.9 million in 2026.
- Per Business Quant data, the three most recent Non Operating Income figures were -$1.9 million in Q1 2026, -$1.8 million in Q4 2025, and -$111.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | -1.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.94 Mn |
| Dec 31, 2025 | -1.84 Mn |
| Sep 30, 2025 | -111.86 Mn |
| Jun 30, 2025 | 5.13 Mn |
| Mar 31, 2025 | -31.56 Mn |
| Dec 31, 2024 | 8.70 Mn |
| Sep 30, 2024 | -2.70 Mn |
| Jun 30, 2024 | 360,000.00 |
| Mar 31, 2024 | 643,000.00 |
| Dec 31, 2023 | 836,000.00 |
| Sep 30, 2023 | 1.14 Mn |
| Jun 30, 2023 | 736,000.00 |
| Mar 31, 2023 | 689,000.00 |
| Dec 31, 2022 | -372,000.00 |
| Sep 30, 2022 | -942,000.00 |
| Jun 30, 2022 | -1.99 Mn |
| Mar 31, 2022 | -1.80 Mn |
| Dec 31, 2021 | -4.81 Mn |
| Sep 30, 2021 | -4.85 Mn |
| Jun 30, 2021 | -4.78 Mn |